Abbott AIDS medicine gets FDA approval earlier than expected.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D004338:Drug Combinations; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D061466:Lopinavir; D011744:Pyrimidinones / Q000627:therapeutic use*; D019438:Ritonavir / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D004338:Drug Combinations; D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D061466:Lopinavir; D019438:Ritonavir